Developmental Pharmacology and Toxicology: Role of Ontogeny (R01, R03, R21)

Funding Agency:
National Institutes of Health

This Funding Opportunity Announcement (FOA) encourages grant applications from institutions or organizations that propose multidisciplinary, investigator-initiated basic and translational research in developmental pharmacology and toxicology. Particular emphasis should be placed on the role of ontogeny on drug metabolizing enzymes, transporters, receptors and signaling pathways across developmental periods from fetal life to adolescence affecting drug action and toxicity.

This FOA will use the NIH R01 grant mechanism and runs in parallel with two FOAs of identical scientific scope: PAR-13-307, that solicits applications under the NIH Small Research Grant (R03) award mechanism, and PAR-13-308, that solicits applications under the NIH Exploratory/Developmental (R21) grant mechanism.


  • Letter of Intent Due Date: 30 days prior to the application due dateĀ 
  • R01 Deadlines: Feb. 5, Jun. 5, Oct. 5
  • R03 and R21 Deadlines: Feb. 16, Jun. 16, Oct. 16

PAR-13-306 Expiration Date: September 8, 2016




Medical - Clinical Science
Medical - Translational

External Deadline

June 5, 2016